Nordea Investment Management
MED icon

Nordea Investment Management’s Medifast MED Stock Holding History

Nordea Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,587
Closed -$1.85M – 932
2024
Q1 		$1.85M Sell
47,587
-181
-0.4% -$8.77K ﹤0.01% 723
2023
Q4 		$3.2M Sell
47,768
-1,873
-4% -$130K ﹤0.01% 630
2023
Q3 		$3.8M Sell
49,641
-434
-0.9% -$38.5K 0.01% 561
2023
Q2 		$4.56M Sell
50,075
-1,205
-2% -$107K 0.01% 529
2023
Q1 		$5.12M Sell
51,280
-1,347
-3% -$149K 0.01% 516
2022
Q4 		$5.89M Sell
52,627
-2,333
-4% -$272K 0.01% 474
2022
Q3 		$6.01M Sell
54,960
-926
-2% -$133K 0.01% 473
2022
Q2 		$10.1M Buy
55,886
+63
+0.1% +$11.3K 0.02% 374
2022
Q1 		$9.48M Buy
55,823
+1,129
+2% +$213K 0.01% 421
2021
Q4 		$11.6M Sell
54,694
-684
-1% -$141K 0.01% 381
2021
Q3 		$10.9M Buy
55,378
+655
+1% +$161K 0.01% 388
2021
Q2 		$15.5M Buy
54,723
+4,450
+9% +$1.21M 0.02% 341
2021
Q1 		$11.1M Buy
50,273
+7
+0% +$1.68K 0.02% 362
2020
Q4 		$9.87M Sell
50,266
-1,028
-2% -$182K 0.02% 364
2020
Q3 		$8.39M Sell
51,294
-50,528
-50% -$8.32M 0.02% 356
2020
Q2 		$14.1M Buy
101,822
+50,909
+100% +$4.67M 0.01% 363
2020
Q1 		$3.24M Buy
50,913
+7,921
+18% +$721K 0.01% 546
2019
Q4 		$4.65M Buy
42,992
+8,726
+25% +$844K 0.01% 562
2019
Q3 		$3.48M Buy
34,266
+578
+2% +$62.1K 0.01% 635
2019
Q2 		$4.32M Sell
33,688
-1,195
-3% -$166K 0.01% 560
2019
Q1 		$4.45M Buy
34,883
+33,783
+3,071% +$4.28M 0.01% 635
2018
Q4 		$138K Sell
1,100
-1,500
-58% -$257K ﹤0.01% 1181
2018
Q3 		$576K Sell
2,600
-4,600
-64% -$933K ﹤0.01% 1093
2018
Q2 		$1.15M Buy
+7,200
New +$921K ﹤0.01% 816

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Nordea Investment Management's MED Position: Q2 2024 in Review

Nordea Investment Management sold out of Medifast (MED) in Q2 2024, closing a stake of 47,587 shares — an estimated $1.85M sold.

Nordea Investment Management first reported a position in MED in Q2 2018 and held it in 24 quarters. The position peaked at $15.5M in Q2 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Nordea Investment Management reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Nordea Investment Management sold 47,587 Medifast shares in Q2 2024, an estimated $1.85M.
  • Nordea Investment Management first reported a position in Medifast in Q2 2018 and held it in 24 quarters.
  • Nordea Investment Management's Medifast position peaked at $15.5M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Nordea Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.